Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone

OBJECTIVE: To compare the impact on thrombin generation of the new combined oral contraceptive containing 15 mg estetrol and 3 mg drospirenone with ethinylestradiol (30 or 20 mcg) associated either with 150 mcg levonorgestrel or with 3 mg drospirenone. METHODS: Data were collected from the “E4/DRSP...

Descripción completa

Detalles Bibliográficos
Autores principales: Morimont, Laure, Jost, Maud, Gaspard, Ulysse, Foidart, Jean-Michel, Dogné, Jean-Michel, Douxfils, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759169/
https://www.ncbi.nlm.nih.gov/pubmed/36099501
http://dx.doi.org/10.1210/clinem/dgac511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759169/
https://www.ncbi.nlm.nih.gov/pubmed/36099501
http://dx.doi.org/10.1210/clinem/dgac511

Ejemplares similares